GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Chugai Pharmaceutical Co 4519.T · JPY

Health Care · Pharmaceuticals · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

6,806

-5.34%

Close of 6 Nov 2026, in JPY

Price performance

Chart by TradingView, with its own licensed prices

Chugai Pharmaceutical Co — daily TSE:4519

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Chugai Pharmaceutical Co on TradingView ↗
Market value
¥11.20trn
Last close × shares
Volume
5.2m
Shares, 6 Nov 2026
Price to earnings
26.1
Dividend yield
1.91%

About Chugai Pharmaceutical Co

Its shares trade on Tokyo Stock Exchange under the ticker 4519.T. It has been listed since 3 March 1956. In the fiscal year to 31 December 2025, it reported revenue of ¥1.26trn and net income of ¥434.01bn. At that date it held total assets of ¥2.47trn and shareholders' equity of ¥2.03trn.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The firm is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The firm operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.

Figures and description from our data supplier, not checked against the company's own report.

More about Chugai Pharmaceutical Co →

Latest on Chugai Pharmaceutical Co

Our reporting

Next results

4 Feb 2027

Due on 4 Feb 2027. Analysts expect earnings of 77.88 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Chugai Pharmaceutical Co's ticker?

Chugai Pharmaceutical Co trades as 4519.T on Tokyo Stock Exchange, under ISIN JP3519400000.

What was Chugai Pharmaceutical Co's last closing price?

6,806 on 6 Nov 2026. The figure is in JPY and is never converted.

When does Chugai Pharmaceutical Co next report results?

Results are expected on 4 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.